Stephen R. Fussell, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 86,279 shares at $59.67 ($5.1M) on 2018-02-20, disclosed to the SEC on 2018-02-21.
Open-market sale of $5.1M ABT by Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.49 | 1,419 | $84K | 1.6% |
| 2 | $59.50 | 1,200 | $71K | 1.4% |
| 3 | $59.51 | 1,172 | $70K | 1.4% |
| 4 | $59.53 | 989 | $59K | 1.1% |
| 5 | $59.60 | 22,500 | $1.3M | 26.1% |
| 6 | $59.63 | 1,600 |
| $95K |
| 1.9% |
| 7 | $59.64 | 1,700 | $101K | 2.0% |
| 8 | $59.65 | 4,794 | $286K | 5.6% |
| 9 | $59.66 | 8,206 | $490K | 9.5% |
| 10 | $59.66 | 3,200 | $191K | 3.7% |
| 11 | $59.67 | 6,028 | $360K | 7.0% |
| 12 | $59.67 | 2,985 | $178K | 3.5% |
| 13 | $59.68 | 2,774 | $166K | 3.2% |
| 14 | $59.69 | 2,300 | $137K | 2.7% |
| 15 | $59.69 | 2,999 | $179K | 3.5% |
| 16 | $59.70 | 1,900 | $113K | 2.2% |
| 17 | $59.71 | 2,900 | $173K | 3.4% |
| 18 | $59.72 | 1,294 | $77K | 1.5% |
| 19 | $59.73 | 1,600 | $96K | 1.9% |
| 20 | $59.75 | 3,100 | $185K | 3.6% |
| 21 | $59.76 | 3,419 | $204K | 4.0% |
| 22 | $59.76 | 1,700 | $102K | 2.0% |
| 23 | $59.77 | 2,500 | $149K | 2.9% |
| 24 | $59.78 | 1,300 | $78K | 1.5% |
| 25 | $59.80 | 1,500 | $90K | 1.7% |
| 26 | $59.82 | 1,200 | $72K | 1.4% |
| Total | $59.66 avg | 86,279 | $5.1M | 100% |
| Filing → |
| ABT | SELL | 2018-03-02 | $668K | — | Filing → |
| ABT | SELL | 2018-02-21 | $108K | — | Filing → |
| ABT | SELL | 2018-02-21 | $65K | — | Filing → |